With virtual meetings on the rise in the age of coronavirus, there are plenty of things you can do to ensure your meetings go without a hitch. Miguel Tovar/University of Houston

Even in the pre-pandemic world, more employees were working remotely in America than ever before. Participating in virtual meetings is the norm, at least for now. The shift came rather abruptly. Millions of Americans had only a few days to make the transition. People are now working on laptops where before they worked on double-screen desktops. Home computers proved to be less convenient to work on since work computers have files and sites already organized for easy access. There are certain things that are more effectively communicated in person than through a screen.

But in 2020, there are myriad conferencing platforms that make it easier than ever to communicate virtually. From Skype and Zoom to Teams and Slack, there is no doubt that virtual work is more convenient than ever. Here are a few tips for how you can develop a personal and professional brand through virtual meetings.

Cast from a carpeted room

When you cast yourself from an empty room with tile or wood flooring, you might notice an echo in your audio. It can sound like you're in a cathedral. Carpeted rooms create much better audio quality. If you're not interested in having your whole room redone, lay down a nice carpet on your floor. This will significantly reduce the reverberation and create a sound that is full and intimate.

Opt for a neutral background

Instinctually, one might think that a shelf full of books, plants and photos might present a professional background. They'd be correct. However, in the interest of a virtual meeting, less is more. A neutral-colored wall such as gray or white would accentuate focus on you. It would keep the viewers' eyes from wandering. Trying to figure out what books you read, who that is in your photos, or judging you from your organizational method (or lack thereof).

Consider your lighting

A dimly lit room can convey a sense of, well, creepiness. Don't be creepy. You want to exude positivity. The best way to achieve this is through nice lighting. You want to make sure your desk has enough lighting on your face to bring out the clarity of it on screen. "I suggest using two LED lights at your desk with adjustable lighting on each side your computer camera. They should face toward you so you can adjust for daylight. Even a single lamp would help."

Use your computer over your phone

I know, this sounds like it should go without saying. But it needs to be said. There are too many people doing conference calls via phone. Your phone should be your absolute last resort in a situation where your computer is down and a meeting is absolutely urgent. Using a computer allows you to take notes and provides for a more stable picture. The audio and video quality is also leagues better on a computer.

Take a tech test

Sure, you can't completely get away with not having any technical issues. But what you can do is minimize the issues you're likely to have. Test your web conferencing program well before you are slated to log on. Be sure to grant all the appropriate permissions prior to logging on for the first time. This will save you tons of time as you continually log on every time afterward. Make sure the camera is set up correctly and that the audio works. If your microphone isn't hooked up to the program, connect it. The more testing you do with your web conferencing tech the less issues you'll have when it's finally time to virtually meet.

------

This article originally appeared on the University of Houston's The Big Idea.

Rene Cantu, the author of this piece, is the writer and editor at UH Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.